skip to main content
Idioma:
Primo Search
Clear Search Box
Search in: Busca Geral
Busca Avançada
Busca por Índices

Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline

Shah, Manish A ; Kennedy, Erin B ; Catenacci, Daniel V ; Deighton, Dana C ; Goodman, Karyn A ; Malhotra, Narinder K ; Willett, Christopher ; Stiles, Brendon ; Sharma, Prateek ; Tang, Laura ; Wijnhoven, Bas P L ; Hofstetter, Wayne L

Journal of clinical oncology, 2020-08, Vol.38 (23), p.2677-2694 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
  • Título:
    Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline
  • Autor: Shah, Manish A ; Kennedy, Erin B ; Catenacci, Daniel V ; Deighton, Dana C ; Goodman, Karyn A ; Malhotra, Narinder K ; Willett, Christopher ; Stiles, Brendon ; Sharma, Prateek ; Tang, Laura ; Wijnhoven, Bas P L ; Hofstetter, Wayne L
  • Assuntos: Combined Modality Therapy ; Esophageal Neoplasms - pathology ; Esophageal Neoplasms - therapy ; Humans ; Randomized Controlled Trials as Topic
  • É parte de: Journal of clinical oncology, 2020-08, Vol.38 (23), p.2677-2694
  • Notas: ObjectType-Article-2
    SourceType-Scholarly Journals-1
    ObjectType-Instructional Material/Guideline-3
    ObjectType-Feature-4
    ObjectType-Undefined-1
    content type line 23
  • Descrição: To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with locally advanced esophageal cancer. ASCO convened an Expert Panel to conduct a systematic review of the more recently published literature (1999-2019) on therapy options for patients with locally advanced esophageal cancer and provide recommended care options for this patient population. Seventeen randomized controlled trials met the inclusion criteria. Where possible, data were extracted separately for squamous cell carcinoma and adenocarcinoma. Multimodality therapy for patients with locally advanced esophageal carcinoma is recommended. For the subgroup of patients with adenocarcinoma, preoperative chemoradiotherapy or perioperative chemotherapy should be offered. For the subgroup of patients with squamous cell carcinoma, preoperative chemoradiotherapy or chemoradiotherapy without surgery should be offered. Additional subgroup considerations are provided to assist with implementation of these recommendations. Additional information is available at www.asco.org/gastrointestinal-cancer-guidelines.
  • Editor: United States
  • Idioma: Inglês
Links
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.